Home
Biotechnology Value Fund II, Director: Kymera Therapeutics KYMR Sell · Filed 06/26
Trade details
- Type
- Insider sale
- Amount
- $12,065,278.5
- Shares · price
- 113,289 sh · $106.50 a share
- Held after
- 240,123 sh
- Trade date
- 26/06/26
- Filed
- 26/06/26
- Days to filing
- 0 days
Sold 32.1% of holdings
- Share of holding sold
- 32.1%
Kymera Therapeutics trades, last 26 weeks
What else happened in Kymera Therapeutics around then
Filed or reported within 30 days of the trade day · 05/27~07/26Biotechnology Value Fund II's recent trades
- Biotechnology Value Fund II
SellKymera Therapeutics
SellKymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
- Biotechnology Value Fund II
SellKymera Therapeutics
SellKymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
- Biotechnology Value Fund II
SellKymera Therapeutics
SellKymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
- Biotechnology Value Fund II
SellMoonLake Immunotherapeutics
SellMoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31
- Biotechnology Value Fund II
SellMoonLake Immunotherapeutics
SellMoonLake Immunotherapeutics
MLTX
$26.3M
1,569,116 sh
$26.3M
Filed 04/02
Traded 03/31
